These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7793453

  • 21. Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Findling RL, Greenhill LL, McNamara NK, Demeter CA, Kotler LA, O'Riordan MA, Myers C, Reed MD.
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):433-45. PubMed ID: 17822339
    [Abstract] [Full Text] [Related]

  • 22. Venlafaxine-induced hair loss.
    Pitchot W, Ansseau M.
    Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract] [Full Text] [Related]

  • 23. Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.
    Wang J, Greenberg H.
    J Clin Sleep Med; 2013 Jul 15; 9(7):715-6. PubMed ID: 23853567
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Benztropine in the treatment of venlafaxine-induced sweating.
    Garber A, Gregory RJ.
    J Clin Psychiatry; 1997 Apr 15; 58(4):176-7. PubMed ID: 9164433
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Venlafaxine withdrawal reactions.
    Louie AK, Lannon RA, Kirsch MA, Lewis TB.
    Am J Psychiatry; 1996 Dec 15; 153(12):1652. PubMed ID: 8942467
    [No Abstract] [Full Text] [Related]

  • 30. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT, Jones L, Chamberlain JC.
    J Clin Psychiatry; 2004 Oct 15; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M.
    Rev Med Liege; 1998 Feb 15; 53(2):106-8. PubMed ID: 9564231
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.
    Ghanizadeh A, Freeman RD, Berk M.
    Rev Recent Clin Trials; 2013 Mar 15; 8(1):2-8. PubMed ID: 23157376
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression.
    Michelson D.
    J Clin Psychiatry; 1999 May 15; 60(5):338-40. PubMed ID: 10362446
    [No Abstract] [Full Text] [Related]

  • 37. Venlafaxine and reversible blepharoedema.
    Reif A, Pfuhlmann B.
    Int J Neuropsychopharmacol; 2002 Dec 15; 5(4):413-4. PubMed ID: 12466039
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.